Logo Logo Logo Logo Logo
  • Home
  • About
    • About Atomo
    • Board of Directors
    • Executive Team
    • Governance
  • OEM Devices
    • Device Platforms
      • Elion RDT platform
      • Pascal RDT platform
      • Galileo RDT platform
      • Losev RDT platform
      • Newton RDT platform
      • Franklin RDT platform
    • OEM Service
      • Development Pathway
  • HIV
    • HIV Professional Use Test
    • HIV Self Testing
  • News
    • News
  • Investor Centre
  • Contact
    • Media Centre
  • Home
  • About
    • About Atomo
    • Board of Directors
    • Executive Team
    • Governance
  • OEM Devices
    • Device Platforms
      • Elion RDT platform
      • Pascal RDT platform
      • Galileo RDT platform
      • Losev RDT platform
      • Newton RDT platform
      • Franklin RDT platform
    • OEM Service
      • Development Pathway
  • HIV
    • HIV Professional Use Test
    • HIV Self Testing
  • News
    • News
  • Investor Centre
  • Contact
    • Media Centre

02 Oct Atomo gains rights to rapid COVID-19 diagnostic

Posted at 12:56h in News by Kavish Buddoo 0 Comments
0 Likes

An article by Biotech Dispatch on our expanded partnership with Access Bio to launch a rapid COVID-19 antigen test in Australia, New Zealand and India.

 

Read the full article >

 

 

Tags:
Atomo Diagnostics, Covid-19
Copyright 2020 Atomo Diagnostics
Privacy Policy
Australia (Head Office) Level 2, 701-703 Parramatta Road, Leichhardt, NSW 2040 Telephone: +61 (0)2 9099 4750